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ABSTRACT  
Objective: Ventilator-induced lung injury has substantive impact on mortality of 
patients with acute respiratory distress syndrome.  Although low tidal volume 
ventilation has been shown to reduce mortality, clinical benefits of open lung strategy 
are controversial.  In this study, we investigated the impact of two distinct forms of 
ventilator-induced lung injury, i.e. volutrauma vs. atelectrauma, on the progression of 
lung injury and inflammation, in particular alveolar and systemic cytokine production. 
Design: Ex vivo study. 
Setting: University research laboratory. 
Subjects: C57/BL6 mice. 
Interventions: Isolated, buffer-perfused lungs were allocated to one of three 
ventilatory protocols for 3 hours: control group received low tidal volume (7ml/kg), 
PEEP (5cmH2O) and regular sustained inflation; high-stretch group received high 
tidal volume (30-32ml/kg) with PEEP (3cmH2O) and sustained inflation; and 
atelectasis group received the same tidal volume as control but neither PEEP nor 
sustained inflation. 
Measurements and Main Results: Both injurious ventilatory protocols developed 
comparable levels of physiological injury and pulmonary edema, measured by 
respiratory system mechanics and lavage fluid protein.  High-stretch induced marked 
increases in pro-inflammatory cytokines in perfusate and lung lavage fluid, compared 
to control.  In contrast, atelectasis had no effect on perfusate cytokines compared to 
control, but did induce some upregulation of lavage cytokines.  Depletion of 
monocytes marginated within the lung microvasculature, achieved by pretreating 
mice with intravenous liposome-encapsulated clodronate, significantly attenuated 
perfusate cytokine levels, especially tumor necrosis factor, in the high-stretch, but 
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not atelectasis group. 
Conclusions: Volutrauma (high-stretch), but not atelectrauma (atelectasis), directly 
activates monocytes within the pulmonary vasculature, leading to cytokine release 
into systemic circulation.  We postulate this as a potential explanation why open lung 
strategy has limited mortality benefits in ventilated critically-ill patients. 
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INTRODUCTION 
Mechanical ventilation can cause or aggravate lung injury leading to significant 
morbidity and mortality in critically-ill patients, a concept known as ventilator-induced 
lung injury (VILI).  Various aspects of ventilation have been proposed as injurious 
based primarily on animal experiments, including overstretch of lungs, termed 
volutrauma, and epithelial shear stress resulting from repetitive collapse and re-
opening of half-atelectatic lung units, termed atelectrauma (1).  In the light of the 
preclinical evidence, ‘protective ventilation’ was designed to reduce VILI, by limiting 
volutrauma through the use of low tidal volumes (VT) as well as preventing 
atelectrauma through the use of high positive end-expiratory pressure (PEEP) or 
recruitment maneuvers (“open-lung” strategy) (2), and has now been embraced by 
clinical practice (3). 
 Although the use of low VT has convincingly been shown to improve mortality 
in patients with acute respiratory distress syndrome (ARDS) (4, 5), the clinical 
benefits of open lung strategy are still controversial (6-11).  This lack of benefits is 
often ascribed to the deleterious physiological interactions of high PEEP such as 
end-inspiratory overstretch, hemodynamic changes, and impaired lymphatic 
drainage (12).  Alternatively, this may be related to our current inadequate 
understanding of the optimal way to prevent atelectasis: for example, more 
sophisticated, personalized titration of PEEP or recruitment maneuvers may be 
essential rather than the protocolized approaches used in clinical trials (13).  
However, this lack of mortality benefits could also originate from fundamental 
differences between volutrauma and atelectrauma in the pathophysiology of VILI, 
particularly in propagation of lung inflammation to systemic organs, which plays a 
crucial role in the development of multi-organ failure  (MOF) and hence considerably 
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affects mortality in ARDS patients (14). 
The present study was designed to explore the nature of lung injury and 
inflammation induced by these two different components of VILI, i.e. volutrauma vs. 
atelectrauma.  It is in general very difficult to reliably or reproducibly model 
atelectrauma in intact animals without using a ‘pre-insult’ to the lungs, and this 
experimental difficulty to create ‘pure’ atelectrauma in vivo has significantly hindered 
our understanding of its pathophysiology.  We therefore developed an ex vivo model 
of VILI using an isolated perfused lung (IPL) system, which enabled us to study not 
only volutrauma but also atelectrauma in healthy mouse lungs.  The results provide 
clear evidence that volutrauma, but not atelectrauma, directly activates monocytes 
marginated within the lung vascular compartment to secrete pro-inflammatory 
cytokines into the systemic circulation.  Our findings offer a previously unappreciated 
hypothesis as to why preventing atelectasis apparently has a much less beneficial 
impact on ARDS patients than reducing VT. 
 
 
MATERIALS AND METHODS  
All protocols were approved by the Ethical Review Board of Imperial College 
London, and carried out under the authority of the UK Home Office in accordance 
with the Animals (Scientific Procedures) Act 1986, UK.  We used male C57BL/6 mice 
(Charles River, Margate, UK) aged 9-12 weeks and weighing 25–30g. 
 
Isolated perfused lung 
The IPL model was prepared using a commercially available miniature organ 
perfusion system (Isolated Perfused Lung Size 1 Type 839; Hugo-Sachs Elektronik, 
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March-Hugstetten, Germany), in a similar fashion to our previous reports (15, 16).  
Mice were anesthetized with intraperitoneal injection of ketamine (130mg/kg) and 
xylazine (13mg/kg), tracheostomized and mechanically ventilated with air.  A midline 
laparotomy was performed and 100 IU of heparin was intravenously injected.  After 
exsanguination from the inferior vena cava, the ventilation gas was changed to 5% 
CO2 in air, the lower half of the body below the liver was severed, and a midline 
thoracotomy was performed with the sternum removed to ensure visibility for 
vascular cannulation.  The animal body was placed in the IPL chamber, and the 
pulmonary artery and left atrium were cannulated with stainless steel cannulae.  
Perfusate was drained from the left atrium to a reservoir, and either drained 
perfusate (recirculating perfusion) or fresh perfusate (non-recirculating perfusion) 
was returned to the pulmonary artery through a heat exchanger and bubble trap, 
using constant-flow peristaltic pumps.  The chamber was water-sealed, humidified, 
and temperature-regulated at 37℃ throughout the experiments. 
 Lungs were perfused at 25ml/kg/min with RPMI-1640 without phenol red 
(Invitrogen, Paisley, UK) supplemented with 4% low-endotoxin bovine serum 
albumin, with left atrial pressure maintained at 2.5mmHg (zero referenced at the 
level of the left atrium) by adjustment of the height of the reservoir.  All lungs were 
initially perfused for 10 minutes (equilibration period) in a non-recirculating manner to 
wash out the residual blood within the pulmonary circulation, and then perfused at 
the same flow rate in a recirculating manner for the subsequent 3 hours.  Complete 
and thorough perfusion was confirmed by the appearance of the lungs during the 
equilibration period: if the level of ‘whiteness’ was inhomogeneous across the lungs, 
the preparation was discarded (in ~5% of the preparations, due mainly to accidental 
displacement of cannulae).  Every hour, perfusate samples were collected for 
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cytokine determination by ELISA (R&D Systems, Abington, UK), and the perfusate 
within the IPL system was exchanged for fresh medium.  At the end of experiments, 
lung lavage was performed using 750µl of saline as described previously (17), and 
the lavage fluid samples were used for cytokine analysis and protein assay (Bio-Rad, 
Hertfordshire, UK).  Some animals were intravenously injected with 200µl of 
liposome-encapsulated clodronate (FormuMax Scientific, Palo Alto, CA) 24 hours 
prior to the IPL experiments, to deplete lung-marginated monocytes. 
 
Mechanical ventilation protocol 
Lungs were ventilated with 7ml/kg VT and 5cmH2O PEEP during the equilibration 
period.  Lungs were then recruited with a sustained inflation (SI; 25cmH2O for 5 
seconds) to minimize any atelectasis developed during the surgical procedure and 
standardize volume history, and allocated to one of three ventilatory protocols: 
control, atelectasis, or high-stretch.  In the control group, lungs were ventilated with 
low VT (7ml/kg) with PEEP (5cmH2O), and regular SI (every 15 minutes) was applied 
to prevent atelectasis.  In the high-stretch group, lungs were ventilated with high VT 
(30-32ml/kg) with both PEEP (3cmH2O) and SI. A lower level of PEEP was chosen 
in the high-stretch group than in the control group, because at PEEP of 5cmH2O the 
lungs ventilated with high VT tend to hit the inner surface of the chest cavity (e.g. the 
incised edge of rib cage as well as remaining diaphragm) at end-inspiration. This 
generates significant changes in surface pressure over the lungs, making it difficult 
to standardize the true transpulmonary pressure. The atelectasis group received the 
same low VT as the control group but neither PEEP nor SI. Respiratory rate was 
maintained at 80/min with an inspiratory-expiratory time ratio of 1:2 in all groups.  At 
the end of the experiments, SI was applied to all the lungs, before respiratory 
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mechanics were evaluated by end-inflation pause technique (17, 18).  This SI was 
applied to separate out unrecruitable pulmonary edema from reversible 
derecruitment.  Ruptured lungs were identified by lack of pressure plateau during the 
end-inflation occlusion, and excluded from analysis. 
 
Flow cytometry 
In a separate group of animals, we used flow cytometry to assess the localization 
and number of leukocytes within the lung tissue.  To determine the localization of 
leukocytes, at the end of the equilibration period, CD45-PE antibody (eBioscience, 
Hatfield, UK) was injected into the pulmonary arterial cannula and incubated for 2 
minutes to stain leukocytes within the lung vasculature, while the lungs were kept 
inflated with 5cmH2O of positive airway pressure.  The unbound residual CD45 
antibody was then washed out by 1-minute non-recirculating perfusion, before 
harvesting lung tissues and preparing single cell suspensions.  Alveolar 
macrophages were all found negative for CD45 after this procedure, indicating that 
the antibody exclusively stains the cells within the intravascular compartment. 
The leukocyte quantification by flow cytometry was performed as previously 
described (16, 19).  Briefly, lung single cell suspensions were prepared by 
mechanical chopping of the harvested lung tissues, and then stained for 30 minutes 
in the dark at 4℃ with antibody cocktail containing; F4/80-FITC, Ly6G-APC 
(Biolegend, London, UK), CD11c-AlexaFluor780 (eBioscience), CD11b-PE-CF594, 
and Ly6C-PE-Cy7 (BD Biosciences, Oxford, UK).  Cell samples were then analyzed 
by a CyAn flow cytometer and Summit software (Beckman Coulter, High Wycombe, 
UK), and further data analysis was performed by FlowJo software (Tree Star, 
Ashland, OR).  Absolute cell counts in samples were determined using microsphere 
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beads (Invitrogen). 
 
Statistical analysis 
Statistical analyses were performed using SPSS version 20 (IBM, Portsmouth, UK). 
Data were analyzed using t-test, 1-way or 2-way ANOVA, following which the 
normality of model residuals was assessed by QQ plot and Shapiro-Wilk test (p<0.05 
considered as skewed distribution). If the distribution was not normal, data was log-
transformed and analyzed by the above parametric tests. If the data distribution 
remained skewed after transformation, non-parametric tests were used, either 
Kruskal-Wallis test or Mann-Whitney’s U test as appropriate.  For assessing the 
time-course data, when only 2 treatment groups were compared we tested the 
interaction between time and treatment by 2-way ANOVA.  For plasma cytokine 
data, we performed end-point analysis by 1-way ANOVA. A p-value < 0.05 was 
considered significant, and to allow for multiple pairwise comparisons we used a 
Bonferroni-corrected cut off of 0.05/n, where n is the number of pairwise 
comparisons. 
 !
RESULTS 
Both high-stretch and atelectasis caused lung injury in IPL 
Both the high-stretch and atelectasis protocol led to substantial increases in peak 
inspiratory pressure (PIP) during the 3-hour ventilation protocol, although the pattern 
of these changes was qualitatively very different (Fig 1A; n=5-6 each).  In the high-
stretch group, PIP was stable (or slightly decreased presumably due to the 
recruitment of any part-collapsed lung regions) for the initial 1.5-2 hours, and then 
exhibited a progressive increase toward the end of experiment.  In contrast, in the 
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atelectasis group, a rapid increase in PIP was apparent within the first hour, 
coinciding with a progressive decrease of the visual lung size both at inspiration and 
expiration, reflecting an ongoing atelectasis of the lungs. After this, PIP remained 
relatively stable (potentially indicating a balance point at which the delivered tidal 
volume was sufficient to prevent further derecruitment) until the last 30 minutes, 
when it started to increase again. In the control group, PIP was stable throughout the 
protocol. 
At the end of the experiment, respiratory system elastance and resistance 
increased substantially in both the high-stretch and atelectasis groups, with 
atelectasis inducing greater percentage increases (compared to control) than high-
stretch (Fig 1B; n=5-6 each).  Lavage fluid protein was also dramatically increased to 
comparable levels following both injury protocols (Fig 1C; n=5-6 each), indicating 
that alveolar-capillary barrier permeability increased to a similar extent following 
either high-stretch or atelectasis.  The development of pulmonary edema in both 
injury groups was further supported by the presence of endotracheal foamy fluid, 
which was never seen following control non-injurious ventilation.  The pulmonary 
arterial pressure (PAP) following the injurious ventilation protocols was not higher 
than that in the control group (Fig 1D; n=5-6 each), suggesting that the physiological 
changes observed were not a result of hydrostatic edema. 
 
Comparison of volutrauma and atelectrauma demonstrated a distinct 
inflammatory pattern 
The production and release of inflammatory mediators have been postulated to play 
a highly important role in VILI, in terms of increasing not only pulmonary but also 
extra-pulmonary organ dysfunction (20-22).  To clarify the impact of the different 
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injurious ventilation strategies on this, we measured levels of keratinocyte-derived 
chemokine (KC) and tumor necrosis factor (TNF) in the vascular compartment (i.e. 
IPL perfusate) as well as in the alveolar compartment (i.e. lavage fluid).  Perfusate 
cytokines showed marked increases during the 3-hour protocol in the high-stretch 
model (Fig 2A; n=5-6 each).  However, in sharp contrast, the atelectasis model 
showed only minor increases in perfusate cytokines, which were almost identical to 
those observed in the control group.  The pattern of intra-alveolar cytokine 
production generally followed that of the perfusate data (Fig 2B; n=5-6 each).  High-
stretch ventilation induced a very substantial upregulation of lavage fluid KC, and a 
more modest, but still significant upregulation of TNF, compared to control 
ventilation. The atelectasis group showed smaller upregulations of lavage fluid KC 
and TNF compared to high-stretch, but still higher than control (albeit not significant 
in TNF with 4 fold increase compared to control). It is important to note that 
atelectasis did not exhibit the same marked increase in perfusate TNF as seen in 
high-stretch, despite comparable levels of lavage fluid TNF (geometric mean 
[95%CI]; 152 [62-372] pg/ml for high-stretch vs 101 [66-153] pg/ml for atelectasis) 
and similarly increased alveolar-capillary barrier permeability.  This suggests that 
increased perfusate TNF during high-stretch was not a consequence of systemic 
spill-over of TNF produced within the alveolar compartment, but rather, originated 
from an extra-alveolar source. 
 
Monocytes in the lung peripheral pool are responsible for the systemic 
cytokine production following high-stretch 
We have previously demonstrated that monocytes within the lung microvasculature 
play an important role in the evolution of lung injury of various etiologies (16, 19, 23, 
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24). In buffer-perfused IPL models, such marginated leukocyte populations have 
generally been considered to be almost completely washed out from the pulmonary 
circulation, along with red blood cells. To investigate this, we utilized flow cytometric 
techniques to determine the number of monocytes and neutrophils remaining within 
the vasculature, after the initial 10 minute wash-out period (i.e. just before the start of 
the injurious ventilation protocols). Unexpectedly, we found substantial numbers of 
intravascular (stained by CD45 antibody infused into the IPL system), lung-
marginated leukocytes remaining within the lung, typically in the range of 5x105 to 
1x106 cells.  To address whether monocytes among these lung-marginated 
leukocyte populations are responsible for the high-stretch induced cytokine 
production observed, we pretreated mice in vivo with liposome-encapsulated 
clodronate. As expected, this procedure almost completely depleted intravascular 
Ly6Chigh and Ly6Clow subsets of monocytes, but was without effect on neutrophils 
(Fig 3; n=4 each). 
We then evaluated the impact of this monocyte depletion on the inflammatory 
and physiological characteristics of the injurious ventilation models. The release of 
cytokines into the vascular compartment (into the IPL perfusate) was significantly 
attenuated in monocyte-depleted lungs exposed to high-stretch ventilation, in 
particular TNF, which was virtually ablated (Fig 4A; n=3-5 each). Interestingly, 
monocyte depletion also significantly attenuated the change in PIP over time during 
high-stretch ventilation (Fig 4B; n=3-5 each), and tended to decrease the lavage 
protein, although this did not reach statistical significance (Fig 4C; n=3-5 each).  In 
contrast, monocyte depletion had no effect on either inflammation or physiological 
deterioration following atelectasis (Fig 5A-C; n=3-5 each). 
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DISCUSSION 
Propagation of lung inflammation to systemic organs and subsequent MOF is a 
major determinant of the mortality of ventilated ARDS patients. The data of the 
present study strongly suggest that monocytes marginated within the lung 
vasculature are responsible for secretion of TNF into the circulation during VILI, 
which only occurs in response to lung overstretch, not atelectasis. This finding may 
have major clinical relevance with regards to the mechanisms as to how mechanical 
ventilation upregulates inflammatory mediators within the systemic circulation. 
In this study, we have taken advantage of ‘zero’ pleural pressure (relative to 
atmospheric pressure) in the open-chest IPL setting to develop an atelectasis-related 
VILI model in healthy mouse lungs, and compared it with a high-stretch induced VILI 
model.  Although atelectasis is common in postoperative and critical care settings 
(25-27), the pathological role and mechanism of atelectasis-related lung injury have 
not been thoroughly investigated, mainly due to difficulties in modeling ‘pure’ 
atelectrauma experimentally.  Inducing significant atelectasis is difficult in large 
animals with intact thorax, because negative pleural pressure and normal surfactant 
function maintain the end-expiratory lung volume above the closing capacity, thereby 
preventing the lungs from developing severe atelectasis. While the lungs of small 
animals, in particular mice which have very little elastic recoil of the chest wall, are 
highly prone to derecruitment during mechanical ventilation in vivo, such models 
induce considerable hemodynamic instability due to impaired gas exchange before 
the development of permeability edema (28). For example, ventilation with zero 
PEEP and low VT in rats in vivo has been shown to result in high mortality mainly 
due to right heart failure induced by hypoxia and pulmonary vasoconstriction, rather 
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than permeability-related ARDS (29, 30).  Therefore, previous experimental 
atelectrauma models have used pre-injury such as surfactant depletion (31, 32) or 
relatively high tidal volume (33, 34) to enhance the atelectasis-related lung injury, but 
these additional insults make mechanistic analyses extremely difficult. Using the IPL 
model, we were able to overcome such limitations and produce homogenous 
atelectasis in a reproducible fashion. We found substantial changes in respiratory 
mechanics and increased barrier permeability (as indicated by increased levels of 
lavage fluid protein) purely by use of low VT with no PEEP or recruitment maneuvers. 
Indeed, barrier permeability deteriorated in the atelectrauma model to a similar 
extent to the high-stretch model. Although the high-stretch ventilation used in the 
current study (VT=30ml/kg) is much higher than is generally considered ‘clinically-
relevant’ in humans, we have recently demonstrated that such high tidal volumes are 
required to produce ‘stretch-induced’ VILI in healthy mouse lungs (28, 35).  
While the high-stretch model clearly increased the cytokine production both in 
the alveolar (lavage fluid) and vascular compartment (IPL perfusate), atelectrauma 
increased these cytokines only in the alveolar compartment. Intriguingly, we found 
that atelectasis induced similar levels of barrier permeability increase and intra-
alveolar TNF upregulation, but much lower levels of TNF within the vascular 
compartment, as compared with high-stretch. This observation provides evidence 
against the generally accepted ‘decompartmentalization’ theory of systemic 
propagation of lung inflammation during VILI (36).  The standard ‘biotrauma’ 
hypothesis proposes that mechanical ventilation promotes injury in non-pulmonary 
organs through the production of cytokines (including TNF) within the alveolar 
compartment, which then leak into the pulmonary and then systemic circulation as 
the alveolar-capillary barrier becomes more permeable (37-40). While such a 
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mechanism may have contributed to some extent to the perfusate cytokine levels in 
the high-stretch group, our data clearly indicate that the source of TNF released into 
the pulmonary vasculature is primarily extra-alveolar. Indeed, Dreyfuss’ pioneering 
work of VILI reported lung endothelial bleb formation after high VT ventilation of just 5 
minutes (41), suggesting that high-stretch VILI can directly injure and activate ‘extra- 
alveolar’ cells within the pulmonary circulation. Furthermore, our data also 
demonstrate that the mechanism for this extra-alveolar TNF production is specifically 
activated in response to high-stretch, but not atelectasis. The difference between 
volutrauma and atelectrauma observed in this study is potentially consistent with the 
recent clinical findings in ARDS patients, showing that metabolic activity of lung 
lesions measured by positron emission tomography was positively correlated with 
plateau pressure and regional tidal volume, but not associated with cyclic 
recruitment-derecruitment (42). 
We have recently demonstrated that lung-marginated monocytes, and their 
interaction with the pulmonary endothelium, are important during acute lung injury of 
various etiologies including VILI (16, 19, 23). In fact, evidence from large animal 
experiments indicated that the lung has arguably the largest peripheral pool of 
leukocytes within its microcirculation, and that trafficking behavior of leukocytes is 
unique within lung microvasculature, where they are tentatively ‘trapped’ even in the 
healthy lung because the size of leukocytes is bigger than the lung capillary diameter 
(43). Previous studies have reported between 1 (16) and 10 million (44) leukocytes 
within the vasculature in healthy mouse lungs. Even following 10 minutes of 
perfusion to wash out blood, we found approximately 0.5 million leukocytes retained 
within the lung vasculature. This population has been almost completely ignored in 
the previous literature of IPL, but has the potential to play an important role in the 
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pathogenesis of lung injury in the IPL models, particularly as a putative source of 
soluble inflammatory mediators. 
To clarify whether monocytes marginated within the lung microvasculature 
play a role in the production of cytokines found in the IPL perfusate, we depleted 
monocytes by in vivo pretreatment with liposome-encapsulated clodronate. In the 
monocyte-depleted lungs, we demonstrated a clear attenuation of TNF and KC 
production in response to high-stretch. The almost complete abrogation of systemic 
(perfusate) TNF production suggests that intravascular monocytes are likely to be 
the major source of TNF, while the partial attenuation of KC upregulation may 
suggest a secondary source. It has been demonstrated that pulmonary endothelial 
cells in isolation are capable of producing IL-8 (i.e. human homologue of KC) (45, 
46). Our data suggest either both monocytes and endothelial cells producing KC, or 
endothelial KC production being regulated by interaction with monocytes within the 
vasculature. Interestingly, monocyte depletion also induced a significant attenuation 
of pulmonary edema in the high-stretch model, a consistent finding with our previous 
in vivo high-stretch model (19). This may suggest that the lung-marginated 
monocytes activated by stretch can also exacerbate pulmonary edema, either 
through direct cellular interaction or producing soluble edemagenic factors. Recent 
literature showed that the mouse IPL produced soluble edemagenic factors in 
response to injurious ventilation with high VT plus low end-expiratory transpulmonary 
pressure (47), but did not attempt to identify a cellular source. Therefore, It is 
possible that stretch-activated lung-marginated monocytes produced such 
edemagenic factors in our high-stretch model. The absence of impact of monocyte 
depletion in the atelectrauma model is compatible with the current proposed 
mechanism of atelectrauma; i.e. repetitive collapse and opening of the lung units, 
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which is primarily an intra-alveolar event (1, 31). 
 
CONCLUSIONS 
In summary, we successfully developed two different ex vivo VILI models of 
volutrauma and atelectrauma, and comparison of these models revealed a distinct 
inflammatory pattern of systemic cytokine release. We have demonstrated that lung-
marginated, intravascular monocytes were activated following high-stretch ventilation 
alone, leading to pro-inflammatory cytokine production and contributing to pulmonary 
edema, potentially challenging the current decompartmentalization paradigm. 
Several physiological and technical reasons have been suggested as to why 
prevention of atelectasis has not been as successful as reducing tidal volume in 
previous clinical trials, and more trials are currently underway in this area. Our study 
provides another piece of novel mechanistic insight to the puzzle, indicating that 
systemic inflammation, which has been postulated to play a major role in determining 
multiple organ failure and death during ARDS, occurs to a much greater extent in 
response to high-stretch than atelectasis.  
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Figure Legends 
Figure 1 
Lungs receiving injurious ventilation protocols display considerable lung injury. (A) 
Time course of peak inspiratory pressure (PIP) in either control, high-stretch, or 
atelectasis ventilation protocol (mean±SD). (B) Elastance (Ers) and resistance (Rrs) 
changes during each 3-hour protocol (shown as box-whisker plots; significant 
differences between 3 groups (p<0.05) found for both Ers and Rrs by Kruskal-Wallis 
1-way ANOVA; *p<0.05 by pairwise Mann-Whitney U test with Bonferroni 
correction). The starting values of Ers were 21.3±2.6 (control), 31.6±0.5 (high-
stretch) and 25.4±2.7 cmH2O/ml (atelectasis), while those of Rrs were 1.00±0.09 
(control), 0.98±0.04 (high-stretch) and 1.00±0.14 cmH2O/µl/sec (atelectasis). (C) 
Lavage protein level (mean+SD; significant difference between 3 groups (p<0.05) 
found by 1-way ANOVA; **p<0.01 by pairwise Bonferroni post hoc test) and (D) 
pulmonary arterial pressure (PAP; perfusion pressure) at the end of each protocol 
(mean+SD). n=5-6 each. 
 
Figure 2 
Lungs receiving injurious ventilation protocols display distinct cytokine profile. (A) 
Time course of KC (mouse homologue of IL-8) and TNF in the perfusate in either 
control, high-stretch, or atelectasis protocol (mean±SD; significant differences 
between 3 groups (p<0.05) found for both KC and TNF by 1-way ANOVA; 
***p<0.001, *p<0.05 vs. control, ✝✝✝p<0.001, ✝p<0.05 vs. atelectasis by pairwise 
Bonferroni post hoc test).  (B) Level of KC and TNF in the lung lavage fluid at the 
end of each 3-hour protocol (geometric mean and 95% confidence interval shown as 
the data required transformation to achieve normal distribution; significant difference  
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between 3 groups (p<0.05) found by 1-way ANOVA; ***p<0.001, *p<0.05 by pairwise 
Bonferroni post hoc test). n=5-6 each. 
 
Figure 3 
A considerable number of leukocytes remain in the isolated perfused lung 
preparation after the initial 10 minute equilibration period with non-recirculating 
perfusion. Leukocytes within the lung vasculature were quantified using flow 
cytometry. CD45 antibody was infused into the pulmonary artery and incubated for 2 
minutes before harvesting the lung sample. Intravascular leukocytes were identified 
as CD45 positive events. Leukocytes were further categorized by their CD11b and 
side scatter characteristics; R1 (high side scatter, CD11b positive events) and R2 
(low side scatter, CD11b positive events). Neutrophils were identified as F4/80 
negative, Ly6G positive population in R1, whereas monocytes were identified as 
F4/80 positive population in R2. Monocyte subsets were determined by their 
expression levels of Ly6C, ‘inflammatory’ monocytes being Ly6C high (R4), and 
‘resident’ monocytes being Ly6C low (R5). Prior treatment of animals with liposome-
encapsulated clodronate clearly decreased the number of both subsets of 
monocytes (geometric mean and 95% confidence interval shown as the data 
required transformation to achieve normal distribution; ***p<0.001 by t-test). n=4 
each. 
 
Figure 4 
Monocyte depletion attenuates systemic cytokine release and pulmonary edema in 
lungs receiving high-stretch ventilation.  (A) Level of KC and TNF in the perfusate at 
3 hours (mean+SD; ***p<0.001, *p<0.05 by t-test). (B) Time course of peak 
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inspiratory pressure (PIP; mean±SD; there is a significant interaction (p<0.05) 
between time and treatment by 2-way ANOVA). (C) Lavage protein level 
(mean+SD). n=3-5 each. 
 
Figure 5 
Monocyte depletion does not affect the progression of atelectasis-related lung injury. 
(A) Level of KC and TNF in the perfusate at 3 hour (mean+SD). (B) Time course of 
peak inspiratory pressure (PIP; mean±SD). (C) Lavage protein level (mean+SD). 
The unpretreated data are those presented in figures 1 and 2.  n=3-5 each. 
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